title: [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
abstract: OBJECTIVE
  Transfusion transmitted bacterial infection is an adverse reaction occurring in a patient during blood transfusion and due to the presence of bacteria in the blood component. For each transfusion transmitted bacterial infection suspicion, clinical and biological investigations should allow to either affirm the accountability of the transfused product in the occurrence of the infection (accountability score 4) or exclude it (accountability score 0). However, among 60,175 adverse reaction sheets extracted from the French e-FIT database (AFSSAPS), 143 are classified as transfusion transmitted bacterial infection diagnosis and 97 of them show a score of accountability 2 (possible). This study aims to analyze these 97 adverse reaction sheets and search for the reasons that led the haemovigilance network actors not to refine the degree of accountability in line with an exclusion or a confirmation of transfusion origin.
  
  
  METHODS
  During collective reading sessions, each adverse reaction sheet among the 97 extracted was re-analyzed with an accountability criteria grid, built beforehand, and proposed in the technical guide sheet for transfusion transmitted bacterial infection (e-Fit AFSSAPS).
  
  
  RESULTS
  Among the 97 analyzed adverse reaction sheets with a score accountability of 2: 12.4 % were considered as "non-analysable"; 54% were reclassified in another diagnosis category: non haemolytic febrile reaction (n=12), unknown diagnosis (n=17); patient infection before transfusion (n=23); blood component's "smear" (n=9); retrograde contamination of blood component (n=5). Finally, only 18.5% adverse reaction sheets (n=18) were maintained with a true diagnosis of transfusion transmitted bacterial infection an accountability score of 2. These cases were in agreement with those described in number 2, 3 or 4 in the annex sheet "Fiche Technique TTBI". 70% of adverse reaction sheets reclassified under another diagnosis as transfusion transmitted bacterial infection had been declared between 2000 and 2004. In order to improve transfusion transmitted bacterial infection suspicions diagnosis approach and to guide the French haemovigilance network in the investigations following a transfusion transmitted bacterial infection suspicion, the group propose recommendations after each adverse reaction sheets category analysis.
  
  
  CONCLUSIONS
  The improvement measures taken as part of the French haemovigilance declaration framework allowed to perfect the data quality of transfusion transmitted bacterial infection. Progresses are still to be made to improve clinical and biological declaration, in order to precise the accountability of a blood component in the occurrence of an adverse transfusion transmitted bacterial infection effect. Tracking transfusion transmitted bacterial infection notifications by a group of experts at the national level is still recommended.
authors.affiliation: Hémovigilance, agence régionale de santé de Franche-Comté, 3, avenue Louise-Michel, 25044 Besançon cedex, France. arlette.delbosc@ars.sante.fr
authors.forename: A
authors.initials: A
authors.lastname: Delbosc
authors.forename: B
authors.initials: B
authors.lastname: Lafeuillade
authors.forename: R
authors.initials: R
authors.lastname: Petermann
authors.forename: F
authors.initials: F
authors.lastname: Eb
authors.forename: N
authors.initials: N
authors.lastname: Ounnoughene
mesh_terms: D016470:Bacteremia / Q000097:blood / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission*; D001419:Bacteria / Q000235:genetics / Q000302:isolation & purification; D016913:Blood Component Transfusion / Q000009:adverse effects; D058731:Blood Safety; D016208:Databases, Factual; D018563:Disease Notification / Q000706:statistics & numerical data*; D055317:Evidence-Based Practice / Q000592:standards; D005568:Forms and Records Control; D005602:France; D005838:Genotype; D006801:Humans; D058996:Quality Improvement; D012189:Retrospective Studies; D012941:Social Responsibility; D065227:Transfusion Reaction